These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 26850987)
1. Chk1 inhibitor synergizes quinacrine mediated apoptosis in breast cancer cells by compromising the base excision repair cascade. Preet R; Siddharth S; Satapathy SR; Das S; Nayak A; Das D; Wyatt MD; Kundu CN Biochem Pharmacol; 2016 Apr; 105():23-33. PubMed ID: 26850987 [TBL] [Abstract][Full Text] [Related]
2. Quinacrine has anticancer activity in breast cancer cells through inhibition of topoisomerase activity. Preet R; Mohapatra P; Mohanty S; Sahu SK; Choudhuri T; Wyatt MD; Kundu CN Int J Cancer; 2012 Apr; 130(7):1660-70. PubMed ID: 21544805 [TBL] [Abstract][Full Text] [Related]
3. PARP inhibitor BMN-673 induced apoptosis by trapping PARP-1 and inhibiting base excision repair via modulation of pol-β in chromatin of breast cancer cells. Sethy C; Kundu CN Toxicol Appl Pharmacol; 2022 Feb; 436():115860. PubMed ID: 34998856 [TBL] [Abstract][Full Text] [Related]
4. Quinacrine and curcumin synergistically increased the breast cancer stem cells death by inhibiting ABCG2 and modulating DNA damage repair pathway. Nayak D; Tripathi N; Kathuria D; Siddharth S; Nayak A; Bharatam PV; Kundu C Int J Biochem Cell Biol; 2020 Feb; 119():105682. PubMed ID: 31877386 [TBL] [Abstract][Full Text] [Related]
5. ABT-888 and quinacrine induced apoptosis in metastatic breast cancer stem cells by inhibiting base excision repair via adenomatous polyposis coli. Siddharth S; Nayak D; Nayak A; Das S; Kundu CN DNA Repair (Amst); 2016 Sep; 45():44-55. PubMed ID: 27334689 [TBL] [Abstract][Full Text] [Related]
6. Resveratrol mediated cell death in cigarette smoke transformed breast epithelial cells is through induction of p21Waf1/Cip1 and inhibition of long patch base excision repair pathway. Mohapatra P; Satapathy SR; Das D; Siddharth S; Choudhuri T; Kundu CN Toxicol Appl Pharmacol; 2014 Mar; 275(3):221-31. PubMed ID: 24467951 [TBL] [Abstract][Full Text] [Related]
7. Talazoparib enhances the quinacrine-mediated apoptosis in patient-derived oral mucosa CSCs by inhibiting BER pathway through the modulation of GCN5 and P300. Das C; Dash SR; Sinha S; Paul S; Das B; Bhal S; Sethy C; Kundu CN Med Oncol; 2023 Nov; 40(12):351. PubMed ID: 37940725 [TBL] [Abstract][Full Text] [Related]
8. Lycopene synergistically enhances quinacrine action to inhibit Wnt-TCF signaling in breast cancer cells through APC. Preet R; Mohapatra P; Das D; Satapathy SR; Choudhuri T; Wyatt MD; Kundu CN Carcinogenesis; 2013 Feb; 34(2):277-86. PubMed ID: 23129580 [TBL] [Abstract][Full Text] [Related]
9. Enhancement of Cytotoxicity and Inhibition of Angiogenesis in Oral Cancer Stem Cells by a Hybrid Nanoparticle of Bioactive Quinacrine and Silver: Implication of Base Excision Repair Cascade. Satapathy SR; Siddharth S; Das D; Nayak A; Kundu CN Mol Pharm; 2015 Nov; 12(11):4011-25. PubMed ID: 26448277 [TBL] [Abstract][Full Text] [Related]
10. An indolocarbazole inhibitor of human checkpoint kinase (Chk1) abrogates cell cycle arrest caused by DNA damage. Jackson JR; Gilmartin A; Imburgia C; Winkler JD; Marshall LA; Roshak A Cancer Res; 2000 Feb; 60(3):566-72. PubMed ID: 10676638 [TBL] [Abstract][Full Text] [Related]
11. Chk1 and Wee1 control genotoxic-stress induced G2-M arrest in melanoma cells. Vera J; Raatz Y; Wolkenhauer O; Kottek T; Bhattacharya A; Simon JC; Kunz M Cell Signal; 2015 May; 27(5):951-60. PubMed ID: 25683911 [TBL] [Abstract][Full Text] [Related]
12. The checkpoint 1 kinase inhibitor LY2603618 induces cell cycle arrest, DNA damage response and autophagy in cancer cells. Wang FZ; Fei HR; Cui YJ; Sun YK; Li ZM; Wang XY; Yang XY; Zhang JG; Sun BL Apoptosis; 2014 Sep; 19(9):1389-98. PubMed ID: 24928205 [TBL] [Abstract][Full Text] [Related]
13. 5‑FU resistance abrogates the amplified cytotoxic effects induced by inhibiting checkpoint kinase 1 in p53‑mutated colon cancer cells. Akasaka T; Tsujii M; Kondo J; Hayashi Y; Ying J; Lu Y; Kato M; Yamada T; Yamamoto S; Inoue T; Tsujii Y; Maekawa A; Fujinaga T; Shiraishi E; Hiyama S; Inoue T; Shinzaki S; Watabe K; Nishida T; Iijima H; Takehara T Int J Oncol; 2015 Jan; 46(1):63-70. PubMed ID: 25310623 [TBL] [Abstract][Full Text] [Related]
14. Hematopoietic cytokines enhance Chk1-dependent G2/M checkpoint activation by etoposide through the Akt/GSK3 pathway to inhibit apoptosis. Jin ZH; Kurosu T; Yamaguchi M; Arai A; Miura O Oncogene; 2005 Mar; 24(12):1973-81. PubMed ID: 15674326 [TBL] [Abstract][Full Text] [Related]
15. A novel mechanism of checkpoint abrogation conferred by Chk1 downregulation. Xiao Z; Xue J; Sowin TJ; Rosenberg SH; Zhang H Oncogene; 2005 Feb; 24(8):1403-11. PubMed ID: 15608676 [TBL] [Abstract][Full Text] [Related]
16. Quinacrine Based Gold Hybrid Nanoparticles Caused Apoptosis through Modulating Replication Fork in Oral Cancer Stem Cells. Hembram KC; Dash SR; Das B; Sethy C; Chatterjee S; Bindhani BK; Kundu CN Mol Pharm; 2020 Jul; 17(7):2463-2472. PubMed ID: 32407635 [TBL] [Abstract][Full Text] [Related]
17. Novel indication for cancer therapy: Chk1 inhibition sensitizes tumor cells to antimitotics. Xiao Z; Xue J; Semizarov D; Sowin TJ; Rosenberg SH; Zhang H Int J Cancer; 2005 Jul; 115(4):528-38. PubMed ID: 15688426 [TBL] [Abstract][Full Text] [Related]
18. Checkpoint kinase 1-mediated phosphorylation of Cdc25C and bad proteins are involved in antitumor effects of loratadine-induced G2/M phase cell-cycle arrest and apoptosis. Chen JS; Lin SY; Tso WL; Yeh GC; Lee WS; Tseng H; Chen LC; Ho YS Mol Carcinog; 2006 Jul; 45(7):461-78. PubMed ID: 16649252 [TBL] [Abstract][Full Text] [Related]
19. Quinacrine induces apoptosis in cancer cells by forming a functional bridge between TRAIL-DR5 complex and modulating the mitochondrial intrinsic cascade. Das S; Tripathi N; Preet R; Siddharth S; Nayak A; Bharatam PV; Kundu CN Oncotarget; 2017 Jan; 8(1):248-267. PubMed ID: 27542249 [TBL] [Abstract][Full Text] [Related]
20. CHIR-124, a novel potent inhibitor of Chk1, potentiates the cytotoxicity of topoisomerase I poisons in vitro and in vivo. Tse AN; Rendahl KG; Sheikh T; Cheema H; Aardalen K; Embry M; Ma S; Moler EJ; Ni ZJ; Lopes de Menezes DE; Hibner B; Gesner TG; Schwartz GK Clin Cancer Res; 2007 Jan; 13(2 Pt 1):591-602. PubMed ID: 17255282 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]